Rocket Pharmaceuticals (RCKT) News Today $8.17 -0.56 (-6.41%) Closing price 04:00 PM EasternExtended Trading$8.26 +0.09 (+1.10%) As of 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Charles Schwab Investment Management Inc. Has $8.25 Million Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Charles Schwab Investment Management Inc. raised its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 15.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 656,090 shares ofMarch 24 at 3:06 AM | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Holdings Boosted by Privium Fund Management B.V.Privium Fund Management B.V. grew its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 34.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 397,650 shares of the biotechnologMarch 20, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Down - What's Next?Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Down - Time to Sell?March 19, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 4.5% - Here's What HappenedRocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Down 4.5% - Should You Sell?March 18, 2025 | marketbeat.comone8zero8 LLC Makes New Investment in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)one8zero8 LLC purchased a new stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 39,700 shares of the biotechnology company's stock, valued at approximately $499,March 17, 2025 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives $43.00 Average Target Price from BrokeragesMarch 17, 2025 | americanbankingnews.comRocket Pharmaceuticals (NASDAQ:RCKT) Research Coverage Started at BMO Capital MarketsMarch 15, 2025 | americanbankingnews.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Rating of "Moderate Buy" from BrokeragesShares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) have been given an average rating of "Moderate Buy" by the twelve research firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and eleven have assigned aMarch 14, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up - Should You Buy?Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up - Still a Buy?March 13, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Coverage Initiated by Analysts at BMO Capital MarketsBMO Capital Markets started coverage on Rocket Pharmaceuticals in a report on Wednesday. They set an "outperform" rating and a $50.00 target price for the company.March 13, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 52-Week Low - Here's What HappenedRocket Pharmaceuticals (NASDAQ:RCKT) Hits New 12-Month Low - What's Next?March 12, 2025 | marketbeat.comRocket Pharmaceuticals initiated with an Outperform at BMO CapitalMarch 11, 2025 | markets.businessinsider.comWhat is Chardan Capital's Estimate for RCKT FY2025 Earnings?Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Investment analysts at Chardan Capital lifted their FY2025 EPS estimates for Rocket Pharmaceuticals in a research note issued on Sunday, March 2nd. Chardan Capital analyst Y. Livshits now expects that the biotechnology company will post eMarch 6, 2025 | marketbeat.comRocket Pharmaceuticals, Inc. (RCKT): A Bull Case TheoryMarch 6, 2025 | msn.comTorray Investment Partners LLC Raises Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Torray Investment Partners LLC grew its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 66.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 122,095 shares of the biotechnology company's stock after purchMarch 4, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Sets New 52-Week Low After Analyst DowngradeRocket Pharmaceuticals (NASDAQ:RCKT) Hits New 12-Month Low Following Analyst DowngradeMarch 3, 2025 | marketbeat.comScotiabank Forecasts Strong Price Appreciation for Rocket Pharmaceuticals (NASDAQ:RCKT) StockScotiabank boosted their target price on shares of Rocket Pharmaceuticals from $51.00 to $52.00 and gave the company a "sector outperform" rating in a research note on Monday.March 3, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Given New $15.00 Price Target at The Goldman Sachs GroupThe Goldman Sachs Group cut their target price on Rocket Pharmaceuticals from $29.00 to $15.00 and set a "neutral" rating on the stock in a research report on Monday.March 3, 2025 | marketbeat.comRocket Pharmaceuticals price target lowered to $36 from $39 at CanaccordMarch 3, 2025 | markets.businessinsider.comRocket Pharmaceuticals (RCKT) Gets a Buy from J.P. MorganMarch 3, 2025 | markets.businessinsider.comCanaccord Genuity Group Issues Pessimistic Forecast for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock PriceCanaccord Genuity Group decreased their price target on shares of Rocket Pharmaceuticals from $39.00 to $36.00 and set a "buy" rating for the company in a research note on Monday.March 3, 2025 | marketbeat.comBrokers Issue Forecasts for RCKT FY2029 EarningsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Stock analysts at Wedbush issued their FY2029 earnings per share estimates for Rocket Pharmaceuticals in a research note issued to investors on Friday, February 28th. Wedbush analyst Y. Zhong expects that the biotechnology company will poMarch 3, 2025 | marketbeat.comWhat is William Blair's Estimate for RCKT Q1 Earnings?Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Research analysts at William Blair issued their Q1 2026 earnings estimates for Rocket Pharmaceuticals in a research report issued on Thursday, February 27th. William Blair analyst S. Corwin expects that the biotechnology company will postMarch 3, 2025 | marketbeat.comWhat is Leerink Partnrs' Estimate for RCKT Q2 Earnings?Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Equities research analysts at Leerink Partnrs issued their Q2 2025 EPS estimates for shares of Rocket Pharmaceuticals in a report released on Thursday, February 27th. Leerink Partnrs analyst M. Foroohar expects that the biotechnology compMarch 3, 2025 | marketbeat.comRocket Pharmaceuticals Rings the Opening BellMarch 2, 2025 | nasdaq.comRocket Pharmaceuticals Rings the Nasdaq Stock Market Opening BellMarch 2, 2025 | nasdaq.comBank of America Securities Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)March 2, 2025 | markets.businessinsider.comRocket Pharmaceuticals (NASDAQ:RCKT) Given New $54.00 Price Target at Chardan CapitalChardan Capital lowered their target price on shares of Rocket Pharmaceuticals from $62.00 to $54.00 and set a "buy" rating for the company in a research note on Friday.March 1, 2025 | marketbeat.comNeedham & Company LLC Issues Pessimistic Forecast for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock PriceNeedham & Company LLC reduced their price target on Rocket Pharmaceuticals from $52.00 to $42.00 and set a "buy" rating on the stock in a research report on Friday.March 1, 2025 | marketbeat.comRocket Pharmaceuticals price target lowered to $15 from $29 at Goldman SachsMarch 1, 2025 | markets.businessinsider.comRocket Pharmaceuticals (NASDAQ:RCKT) Posts Earnings Results, Beats Estimates By $0.06 EPSRocket Pharmaceuticals (NASDAQ:RCKT - Get Free Report) issued its earnings results on Thursday. The biotechnology company reported ($0.62) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.68) by $0.06.February 28, 2025 | marketbeat.comRocket Pharmaceuticals price target lowered to $54 from $62 at ChardanFebruary 28, 2025 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Rocket Pharmaceuticals (RCKT), Janux Therapeutics Inc (JANX)February 27, 2025 | markets.businessinsider.comRocket Pharmaceuticals reports Q4 EPS (62c), consensus (72c)February 27, 2025 | markets.businessinsider.comRocket Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent ProgressFebruary 27, 2025 | businesswire.comBronstein, Gewirtz & Grossman, LLC Encourages Rocket Lab USA, Inc. (RKLB) Investors to Inquire about Securities InvestigationFebruary 26, 2025 | markets.businessinsider.comRocket Pharmaceuticals (NASDAQ:RCKT) Hits New 1-Year Low - Here's What HappenedRocket Pharmaceuticals (NASDAQ:RCKT) Hits New 1-Year Low - Here's What HappenedFebruary 25, 2025 | marketbeat.comBleecker Street Research short Rocket Lab, says ‘materially misled investors’February 25, 2025 | markets.businessinsider.comRocket Pharmaceuticals (RCKT) Projected to Post Earnings on MondayRocket Pharmaceuticals (NASDAQ:RCKT) will be releasing earnings before the market opens on Monday, February 24, Financial Modeling Prep reports.February 17, 2025 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) have earned a consensus rating of "Moderate Buy" from the twelve ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and eleven have issued a buyFebruary 17, 2025 | marketbeat.comRocket Pharma Is A Buy At These Prices With Promising DataFebruary 12, 2025 | seekingalpha.comPokemon TCG's Destined Rivals Set Brings Team Rocket Back In MayFebruary 11, 2025 | msn.comSovran Advisors LLC Takes Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Sovran Advisors LLC bought a new position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 150,767 shares of the biotechnologyFebruary 11, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Sets New 1-Year Low - Time to Sell?Rocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 1-Year Low - Should You Sell?February 10, 2025 | marketbeat.comJennison Associates LLC Acquires 29,564 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Jennison Associates LLC raised its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 72.6% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 70,304 shares of the biotechnology company's stock after acquiriFebruary 7, 2025 | marketbeat.comSG Americas Securities LLC Acquires 48,793 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)SG Americas Securities LLC lifted its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 796.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 54,921 shares of the biotechnology company's stockJanuary 31, 2025 | marketbeat.comRocket Lab: With A Rosy Outlook Ahead, I'm Waiting For A Discount To BuyJanuary 27, 2025 | seekingalpha.comRocket Pharmaceuticals vice president sells $9,300 in stockJanuary 27, 2025 | msn.comFY2024 Earnings Estimate for RCKT Issued By Leerink PartnrsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Research analysts at Leerink Partnrs increased their FY2024 earnings per share estimates for shares of Rocket Pharmaceuticals in a report released on Wednesday, January 22nd. Leerink Partnrs analyst M. Foroohar now anticipates that the biJanuary 24, 2025 | marketbeat.comCantor Fitzgerald Forecasts RCKT FY2025 EarningsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Rocket Pharmaceuticals in a research note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst J. Schimmer forecastsJanuary 23, 2025 | marketbeat.com Remove Ads Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address RCKT Media Mentions By Week RCKT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCKT News Sentiment▼1.300.62▲Average Medical News Sentiment RCKT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCKT Articles This Week▼36▲RCKT Articles Average Week Remove Ads Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SWTX News Today RARE News Today AKRO News Today ALVO News Today RYTM News Today MRUS News Today CRNX News Today IMVT News Today VKTX News Today PTGX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RCKT) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RCKT Stock Free RCKT Stock Alerts